Treatment strategies and prognostic factors in secondary central nervous system lymphoma: a multicenter study of 124 patients

Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively treated and with clinical long-term follow-up were inc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Treiber, Hannes (VerfasserIn) , Nilius-Eliliwi, Verena (VerfasserIn) , Seifert, Nicole (VerfasserIn) , Vangala, Deepak (VerfasserIn) , Wang, Meng (VerfasserIn) , Seidel, Sabine (VerfasserIn) , Mika, Thomas (VerfasserIn) , Marschner, Dominik (VerfasserIn) , Zeremski, Vanja (VerfasserIn) , Wurm-Kuczera, Rebecca (VerfasserIn) , Caillé, Léandra (VerfasserIn) , Chapuy, Claudia I. (VerfasserIn) , Trümper, Lorenz (VerfasserIn) , Fischer, Thomas (VerfasserIn) , Altenbuchinger, Michael Christoph (VerfasserIn) , Wulf, Gerald (VerfasserIn) , Illerhaus, Gerald (VerfasserIn) , Dietrich, Sascha (VerfasserIn) , Schroers, Roland (VerfasserIn) , Chapuy, Björn (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2023
In: HemaSphere
Year: 2023, Jahrgang: 7, Heft: 8, Pages: 1-12
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000926
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1097/HS9.0000000000000926
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/hemasphere/fulltext/2023/08000/treatment_strategies_and_prognostic_factors_in.9.aspx
Volltext
Verfasserangaben:Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, Deepak Vangala, Meng Wang, Sabine Seidel, Thomas Mika, Dominik Marschner, Vanja Zeremski, Rebecca Wurm-Kuczera, Leandra Caillé, Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald G. Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Björn Chapuy

MARC

LEADER 00000caa a2200000 c 4500
001 1858147832
003 DE-627
005 20240307055339.0
007 cr uuu---uuuuu
008 230829s2023 xx |||||o 00| ||eng c
024 7 |a 10.1097/HS9.0000000000000926  |2 doi 
035 |a (DE-627)1858147832 
035 |a (DE-599)KXP1858147832 
035 |a (OCoLC)1425212351 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Treiber, Hannes  |e VerfasserIn  |0 (DE-588)130035819X  |0 (DE-627)1858148685  |4 aut 
245 1 0 |a Treatment strategies and prognostic factors in secondary central nervous system lymphoma  |b a multicenter study of 124 patients  |c Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, Deepak Vangala, Meng Wang, Sabine Seidel, Thomas Mika, Dominik Marschner, Vanja Zeremski, Rebecca Wurm-Kuczera, Leandra Caillé, Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald G. Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Björn Chapuy 
264 1 |c August 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.08.2023 
520 |a Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively treated and with clinical long-term follow-up were included. Initial histopathology, as divided in low-grade, other aggressive, and diffuse large B-cell lymphoma (DLBCL), was of prognostic significance. Overall response to induction treatment was a prognostic factor with early responding DLBCL-SCNSL in comparison to those non-responding experiencing a significantly better progression-free survival (PFS) and overall survival (OS). However, the type of induction regime was not prognostic for survival. Following consolidating high-dose chemotherapy and autologous stem cell transplantation (HDT-ASCT), DLBCL-SCNSL patients had better median PFS and OS. The important role of HDT-ASCT was further highlighted by favorable responses and survival of patients not responding to induction therapy and by excellent results in patients with de novo DLBCL-SCNSL (65% long-term survival). SCNSL identified as a progression of disease within 6 months of initial systemic lymphoma presentation represented a previously not appreciated subgroup with particularly dismal outcome. This temporal stratification model of SCNSL diagnosis revealed CNS progression of disease within 6 months as a promising candidate prognosticator for future studies. 
700 1 |a Nilius-Eliliwi, Verena  |e VerfasserIn  |0 (DE-588)1254002936  |0 (DE-627)1796467529  |4 aut 
700 1 |a Seifert, Nicole  |e VerfasserIn  |4 aut 
700 1 |a Vangala, Deepak  |e VerfasserIn  |0 (DE-588)1244402516  |0 (DE-627)1775653234  |4 aut 
700 1 |a Wang, Meng  |e VerfasserIn  |4 aut 
700 1 |a Seidel, Sabine  |e VerfasserIn  |0 (DE-588)124564775X  |0 (DE-627)1777338867  |4 aut 
700 1 |a Mika, Thomas  |d 1989-  |e VerfasserIn  |0 (DE-588)1128612089  |0 (DE-627)882983695  |0 (DE-576)485943905  |4 aut 
700 1 |a Marschner, Dominik  |d 1991-  |e VerfasserIn  |0 (DE-588)1228911401  |0 (DE-627)1750851873  |4 aut 
700 1 |a Zeremski, Vanja  |e VerfasserIn  |4 aut 
700 1 |a Wurm-Kuczera, Rebecca  |e VerfasserIn  |4 aut 
700 1 |a Caillé, Léandra  |e VerfasserIn  |0 (DE-588)1241688362  |0 (DE-627)1771620951  |4 aut 
700 1 |a Chapuy, Claudia I.  |e VerfasserIn  |4 aut 
700 1 |a Trümper, Lorenz  |e VerfasserIn  |0 (DE-588)110778251  |0 (DE-627)53749197X  |0 (DE-576)289683270  |4 aut 
700 1 |a Fischer, Thomas  |d 1958-  |e VerfasserIn  |0 (DE-588)1257794345  |0 (DE-627)1802480323  |4 aut 
700 1 |a Altenbuchinger, Michael Christoph  |e VerfasserIn  |0 (DE-588)1048483894  |0 (DE-627)780537793  |0 (DE-576)402312791  |4 aut 
700 1 |a Wulf, Gerald  |d 1966-  |e VerfasserIn  |0 (DE-588)172647010  |0 (DE-627)697580830  |0 (DE-576)133505766  |4 aut 
700 1 |a Illerhaus, Gerald  |d 1969-  |e VerfasserIn  |0 (DE-588)12045422X  |0 (DE-627)080684602  |0 (DE-576)292227175  |4 aut 
700 1 |a Dietrich, Sascha  |d 1979-  |e VerfasserIn  |0 (DE-588)136406300  |0 (DE-627)694354635  |0 (DE-576)301003408  |4 aut 
700 1 |a Schroers, Roland  |d 1970-  |e VerfasserIn  |0 (DE-588)11816239X  |0 (DE-627)07927997X  |0 (DE-576)291746608  |4 aut 
700 1 |a Chapuy, Björn  |d 1977-  |e VerfasserIn  |0 (DE-588)131464736  |0 (DE-627)707638615  |0 (DE-576)298495511  |4 aut 
773 0 8 |i Enthalten in  |t HemaSphere  |d Hoboken : John Wiley & Sons Ltd., 2017  |g 7(2023), 8 vom: Aug., Artikel-ID e926, Seite 1-12  |h Online-Ressource  |w (DE-627)1015324924  |w (DE-600)2922183-3  |w (DE-576)500571066  |x 2572-9241  |7 nnas  |a Treatment strategies and prognostic factors in secondary central nervous system lymphoma a multicenter study of 124 patients 
773 1 8 |g volume:7  |g year:2023  |g number:8  |g month:08  |g elocationid:e926  |g pages:1-12  |g extent:12  |a Treatment strategies and prognostic factors in secondary central nervous system lymphoma a multicenter study of 124 patients 
856 4 0 |u https://doi.org/10.1097/HS9.0000000000000926  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://journals.lww.com/hemasphere/fulltext/2023/08000/treatment_strategies_and_prognostic_factors_in.9.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230829 
993 |a Article 
994 |a 2023 
998 |g 136406300  |a Dietrich, Sascha  |m 136406300:Dietrich, Sascha  |d 910000  |d 910100  |d 50000  |e 910000PD136406300  |e 910100PD136406300  |e 50000PD136406300  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 18 
998 |g 1241688362  |a Caillé, Léandra  |m 1241688362:Caillé, Léandra  |d 50000  |e 50000PC1241688362  |k 0/50000/  |p 11 
999 |a KXP-PPN1858147832  |e 4370706408 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"HemaSphere","title":"HemaSphere","subtitle":"open access journal of the European Hematology Association"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Volume 1, issue 1 (December 2017)-"],"language":["eng"],"corporate":[{"display":"European Hematology Association","role":"isb"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.01.2024"],"part":{"year":"2023","issue":"8","extent":"12","text":"7(2023), 8 vom: Aug., Artikel-ID e926, Seite 1-12","pages":"1-12","volume":"7"},"id":{"eki":["1015324924"],"zdb":["2922183-3"],"issn":["2572-9241"]},"origin":[{"publisherPlace":"Hoboken ; [Philadelphia, Pennsylvania]","dateIssuedKey":"2024","publisher":"John Wiley & Sons Ltd. ; Wolters Kluwer Health","dateIssuedDisp":"2024-"}],"disp":"Treatment strategies and prognostic factors in secondary central nervous system lymphoma a multicenter study of 124 patientsHemaSphere","recId":"1015324924"}],"note":["Gesehen am 29.08.2023"],"id":{"eki":["1858147832"],"doi":["10.1097/HS9.0000000000000926"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"August 2023"}],"name":{"displayForm":["Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, Deepak Vangala, Meng Wang, Sabine Seidel, Thomas Mika, Dominik Marschner, Vanja Zeremski, Rebecca Wurm-Kuczera, Leandra Caillé, Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald G. Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Björn Chapuy"]},"recId":"1858147832","person":[{"given":"Hannes","role":"aut","family":"Treiber","display":"Treiber, Hannes"},{"given":"Verena","role":"aut","family":"Nilius-Eliliwi","display":"Nilius-Eliliwi, Verena"},{"family":"Seifert","given":"Nicole","role":"aut","display":"Seifert, Nicole"},{"display":"Vangala, Deepak","role":"aut","given":"Deepak","family":"Vangala"},{"display":"Wang, Meng","family":"Wang","role":"aut","given":"Meng"},{"role":"aut","given":"Sabine","family":"Seidel","display":"Seidel, Sabine"},{"display":"Mika, Thomas","family":"Mika","given":"Thomas","role":"aut"},{"role":"aut","given":"Dominik","family":"Marschner","display":"Marschner, Dominik"},{"given":"Vanja","role":"aut","family":"Zeremski","display":"Zeremski, Vanja"},{"display":"Wurm-Kuczera, Rebecca","family":"Wurm-Kuczera","role":"aut","given":"Rebecca"},{"display":"Caillé, Léandra","family":"Caillé","role":"aut","given":"Léandra"},{"role":"aut","given":"Claudia I.","family":"Chapuy","display":"Chapuy, Claudia I."},{"family":"Trümper","given":"Lorenz","role":"aut","display":"Trümper, Lorenz"},{"given":"Thomas","role":"aut","family":"Fischer","display":"Fischer, Thomas"},{"given":"Michael Christoph","role":"aut","family":"Altenbuchinger","display":"Altenbuchinger, Michael Christoph"},{"display":"Wulf, Gerald","role":"aut","given":"Gerald","family":"Wulf"},{"family":"Illerhaus","role":"aut","given":"Gerald","display":"Illerhaus, Gerald"},{"display":"Dietrich, Sascha","family":"Dietrich","given":"Sascha","role":"aut"},{"display":"Schroers, Roland","family":"Schroers","given":"Roland","role":"aut"},{"display":"Chapuy, Björn","role":"aut","given":"Björn","family":"Chapuy"}],"title":[{"title_sort":"Treatment strategies and prognostic factors in secondary central nervous system lymphoma","title":"Treatment strategies and prognostic factors in secondary central nervous system lymphoma","subtitle":"a multicenter study of 124 patients"}],"language":["eng"],"physDesc":[{"extent":"12 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a TREIBERHANTREATMENTS2023